Breakthrough CAR-T Cancer Treatment for Patients with Non-Hodgkin’s Lymphoma

Baylor University Medical Center and Texas Oncology is now offering CAR-T cancer therapy to treat diffuse large B-cell lymphoma (DLBCL). They are among the first in the nation to treat patients with the only CAR-T cell therapy approved by the Food and Drug Administration (FDA) to treat this form of cancer.